| Enrolment | Baseline | 2 weeks | 6 weeks | 12 weeks |
---|---|---|---|---|---|
ENROLMENT: | |||||
 Eligibility screen | x |  |  |  |  |
 Informed consent | x |  |  |  |  |
 Clinical assessment |  | x |  |  |  |
 Randomisation |  | x |  |  |  |
INTERVENTION: | |||||
 Amitriptyline, 25 mg nocte |  | Alternate | Nightly | Nightly | Nightly |
 Benztropine, 1 mg, nocte |  | Alternate | Nightly | Nightly | Nightly |
ASSESSMENTS | |||||
 Primary and secondary outcomes | |||||
  WOMAC (pain, stiffness, function, total) |  | x |  |  | x |
 Other measures of knee pain | |||||
  Pain severity (NRS, 0–10) |  | x | x | x | x |
  Pain severity (VAS, 100 mm), pain diagram |  | x |  |  | x |
  PainDETECT |  | x |  |  | x |
 Functional status and severity | |||||
  ACR functional class I, II or III |  | x |  |  | x |
  Investigator assessed global assessment of OA status (Likert, 0 very well–4 very poor) |  | x |  |  | x |
  General health status (AQOL-8D) |  | x |  |  | x |
  Leg muscle strength (in triplicate) |  | x |  |  | x |
  Xray – KL score, osteophytes, JSN |  | x |  |  |  |
 Other measures of response | |||||
  Pain acceptability (48 h) |  | x |  |  | x |
  Patient global impression of change (Likert, 0–7) |  |  | x | x | x |
 Other measures | |||||
  Inclusion criteria: pain & 1 of age > 50, stiff <30mins, Crepitus, osteophytes and KOA |  | x |  |  |  |
  Age, height, weight, bp, smoking |  | x |  |  |  |
  Medical conditions |  | x |  |  | x |
  Education (category), Employment current status, type of work (manual, office, NA) |  | x |  |  |  |
  Medications – analgesics, NSAID, opioid |  | x |  |  | x |
  Fear of movement (TSK) |  | x |  |  | x |
  Mood disorder (HADS) |  | x |  |  | x |
  Physical activity (IPAQ, 7 days) |  | x |  |  | x |
  Sleep quality and disturbance (PSQI) |  | x |  |  | x |
 Treatment and safety issues | |||||
  Medications – analgesics, NSAID, opioid |  | x |  |  | x |
  Treatment belief: study drug or placebo |  |  |  |  | x |
  Rating of medication and side effects (Scale, excellent, good, fair, poor, unacceptable) |  |  |  |  | x |
  UKU |  | x | x | x | x |
  Adverse events |  |  | x | x | x |
  Adherence, pill count |  |  |  |  | x |